RxDoctor Payments Data

Stephanie Kraft, MD

Internal Medicine · Parker, CONPI 1104876721

Payments from drug & device makers

$558in general payments, 2019–2025

Across 34 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$120
  • Pfizer$90
  • Novo Nordisk$75
  • Novartis$53
  • Johnson & Johnson$48
  • Lilly USA, LLC$45
  • plus $127 from 8 others

What the payments were for

  • Food & beverage$54798%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$558 in reported general payments places this provider in the 80th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$75,230
Medicare patients
258
Services billed
949

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban59$61,587
OzempicSemaglutide39$37,481
MounjaroTirzepatide16$30,092
JardianceEmpagliflozin22$24,314
XareltoRivaroxaban21$23,114
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$10,204
Breo ElliptaFluticasone/Vilanterol14$5,656
SynthroidLevothyroxine Sodium23$2,896
Atorvastatin Calcium189$2,258
Fentanyl16$1,871
Gabapentin70$1,426
Levothyroxine Sodium109$1,406
Nebivolol Hcl16$1,315
Valsartan35$1,174
Vilazodone Hcl14$977

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$90$61,58759 claims
Novo NordiskOzempic$75$37,48139 claims
Lilly USA, LLCMounjaro$45$30,09216 claims
Johnson & JohnsonXarelto$48$23,11421 claims
AbbVieSynthroid$12$2,89623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,430 internal medicine providers in Colorado.

Other internal medicine in Parker

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →